Phase I trial of recombinant granulocyte-macrophage colony stimulating factor in patients with lung cancer: clinical and immunologic effects - Bukowski, RM; Murty, S; McLain, D; Finke, J; Andresen, S; Tubbs, R; Bauer, L; Gibson, V; Budd, GT; Thomassen, MJ (J Immunother, 1993)